Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  MannKind Corporation    MNKD   US56400P2011

Delayed Quote. Delayed Nasdaq - 11/21 04:00:01 pm
6.18 USD   +0.49%
11/05DJMannKind's Progress Seen More Gradual -- Barron's
11/04DJMannKind's Progress Seen More Gradual -- Barron's
11/03 MANNKIND : reports 3Q loss
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

MannKind Corporation : MNKD, MU, ALXN and GMCR added to NASDAQ Active Stock Watch List at EPR

07/16/2013 | 09:05am US/Eastern

New York, NY - (ACCESSWIRE) - 07/16/2013 - Equity Profile Report initiates its NASDAQ Active Stock Watch List adding MannKind Corp. (NASDAQ:MNKD), Micron Technology Inc. (NASDAQ:MU), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Green Mountain Coffee Roasters, Inc. (NASDAQ:GMCR),

MannKind Corp. (NASDAQ:MNKD) a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States closed up in its previous session (+6.47%) on 7,469,136 shares traded. MannKind Corp. (NASDAQ:MNKD) is currently up (+310.99%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about MannKind Corp. (NASDAQ:MNKD)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=MNKD&SubId=AW

Micron Technology Inc. (NASDAQ:MU) a company that together with its subsidiaries, engages in manufacturing and marketing semiconductor devices worldwide closed up in its previous session (+2.99%) on 29,731,748 shares traded after Micron Technology Inc reported its Financials. Micron Technology Inc. (NASDAQ:MU) is currently up (+155.62%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about Micron Technology Inc. (NASDAQ:MU)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=MU&SubId=AW

Also mentioned in Equity Profile Report?s NASDAQ Active Stock Watch List and Investor Poll was: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Green Mountain Coffee Roasters, Inc. (NASDAQ:GMCR), Groupon, Inc. (NASDAQ:GRPN) and Zynga, Inc. (NASDAQ:ZNGA)

To see what other investors are saying about: ALXN, GMCR, GRPN, ZNGA

Click here: http://www.equityprofilereport.com/PR.aspx?stock=ALXN-GMCR-GRPN-ZNGA&SubId=AW

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed. Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:

Equity Profile Report

editor@Equityprofilereport.com


© Accesswire 2013
React to this article
Latest news on MANNKIND CORPORATION
11/10 MANNKIND : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
11/05DJMannKind's Progress Seen More Gradual -- Barron's
11/04DJMannKind's Progress Seen More Gradual -- Barron's
11/03 MANNKIND : Results of Operations and Financial Condition, Financial Statements a..
11/03 MANNKIND : reports 3Q loss
11/03 MANNKIND : Reports 2014 Third Quarter Financial Results
10/29 MANNKIND : "Method of Drug Formulation Based on Increasing the Affinity of Cryst..
10/27 MANNKIND : to Hold 2014 Third Quarter Financial Results Conference Call on Novem..
10/08 MANNKIND : Patent Issued for Monoclonal Antibodies and Diagnostic Uses
10/02 MANNKIND : Assigned Patent
Advertisement
Chart
Duration : Period :
MannKind Corporation Technical Analysis Chart | MNKD | US56400P2011 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF